The German Biotechnology Sector 2017 - The biotech growth engine

The German Biotechnology Sector 2017 - The biotech growth engine

2017

Biotechnology in Germany is a growth engine. In 2016, all key figures such as employees, turnover and R&D expenditure were at an all-time high. Among the drivers are medical innovations, but also an upward trend of green chemistry.

The report provides an overview to the current status of the German biotechnology sector. The figures and data presented are based on a biotechnology company survey which has been conducted by BIOCOM for the 11th time via the information platform biotechnologie.de.

Nachrichten unserer Mitglieder

  • BRAIN und SAMS nutzen die BEC-Genom-Editing-Technologie zur gemeinsamen Entwicklung innovativer Omega-3-Präparate aus marinen Organismen

    BRAIN Biotech AG 3.11.2021Mehr
  • Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology

    Insilico Biotechnology AG 2.11.2021Mehr
  • Capital Markets Day der BRAIN Biotech AG: Im Fokus stand die BEC-Technologie und deren Potenzial für das Unternehmen

    BRAIN Biotech AG 3.09.2021Mehr
  • Alle Links